220 related articles for article (PubMed ID: 17114339)
1. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
[TBL] [Abstract][Full Text] [Related]
2. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
Liu X; Zhao D; Qin L; Li J; Zeng H
J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
[TBL] [Abstract][Full Text] [Related]
3. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
4. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
5. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
Liu X; Zhao D; James L; Li J; Zeng H
FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
[TBL] [Abstract][Full Text] [Related]
6. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
[TBL] [Abstract][Full Text] [Related]
7. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
[TBL] [Abstract][Full Text] [Related]
8. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.
Cui P; Liu X; Zhao K; Hou S; Chen C; Zhao D; Zeng H
Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305
[TBL] [Abstract][Full Text] [Related]
9. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
Chen C; Cui P; Zhao K; Niu G; Hou S; Zhao D; Zeng H
Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
[TBL] [Abstract][Full Text] [Related]
10. Plasma membrane calcium ATPase isoform 4 inhibits vascular endothelial growth factor-mediated angiogenesis through interaction with calcineurin.
Baggott RR; Alfranca A; López-Maderuelo D; Mohamed TM; Escolano A; Oller J; Ornes BC; Kurusamy S; Rowther FB; Brown JE; Oceandy D; Cartwright EJ; Wang W; Gómez-del Arco P; Martínez-Martínez S; Neyses L; Redondo JM; Armesilla AL
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2310-20. PubMed ID: 25147342
[TBL] [Abstract][Full Text] [Related]
11. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
[TBL] [Abstract][Full Text] [Related]
12. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway.
Cano E; Canellada A; Minami T; Iglesias T; Redondo JM
J Biol Chem; 2005 Aug; 280(33):29435-43. PubMed ID: 15975916
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor of activated T cells and early growth response-1 cooperate to mediate tissue factor gene induction by vascular endothelial growth factor in endothelial cells.
Schabbauer G; Schweighofer B; Mechtcheriakova D; Lucerna M; Binder BR; Hofer E
Thromb Haemost; 2007 Jun; 97(6):988-97. PubMed ID: 17549302
[TBL] [Abstract][Full Text] [Related]
14. Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.
Zheng JC; Chang KJ; Jin YX; Zhao XW; Li B; Yang MH
Med Sci Monit; 2019 Mar; 25():2228-2237. PubMed ID: 30913205
[TBL] [Abstract][Full Text] [Related]
15. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.
Ryeom S; Baek KH; Rioth MJ; Lynch RC; Zaslavsky A; Birsner A; Yoon SS; McKeon F
Cancer Cell; 2008 May; 13(5):420-31. PubMed ID: 18455125
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1.
Yang MH; Wang YS; Shi XQ; Zhao XW; Li B
Curr Cancer Drug Targets; 2022; 22(10):854-864. PubMed ID: 35770414
[TBL] [Abstract][Full Text] [Related]
17. The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.
Siamakpour-Reihani S; Caster J; Bandhu Nepal D; Courtwright A; Hilliard E; Usary J; Ketelsen D; Darr D; Shen XJ; Patterson C; Klauber-Demore N
PLoS One; 2011; 6(6):e20412. PubMed ID: 21673995
[TBL] [Abstract][Full Text] [Related]
18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
19. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
20. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
Chan B; Greenan G; McKeon F; Ellenberger T
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13075-80. PubMed ID: 16131541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
